Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Similar content being viewed by others Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have revolutionized the treatment landscape for type 2 diabetes mellitus (T2DM) and obesity, offering significant benefits in glycemic control, weight reduction, and cardiometabolic protection
How PlexusDx Supports a More Personalized Approach Genetic variation in GLP-1 receptor expression and related peptide-signaling pathways influences individual semaglutide response
Drug Interactions and Allergy Risk in Semaglutide Users When taking any medication, it is important to understand how it may interact with other drugs
In terms of calorie reduction, the survey shows an average ~500 calorie reduction (or ~18.5%) for respondents using GLP-1 drugs, compared to a ~600 calorie reduction (or ~23.1%) for respondents using other weight loss methods
The Bridge only covers GLP-1s prescribed for weight management
